MIPS 2022—What’s New With Cost
Excerpted from “MIPS—What’s New for 2022, Part 1: Scoring, Bonuses, and Penalties” (EyeNet, January 2022). Also see, EyeNet’s MIPS Manual 2022: A Primer and Reference.
The cost performance category is largely unchanged. As in 2021, the cost measure that is most likely to apply to ophthalmologists is the measure for routine cataract surgery.
Five new episode-based measures. For 2022, CMS added five episode-based measures:
- two procedural measures (one on melanoma resection, the other on colon and rectal resection);
- one acute inpatient measure (sepsis); and
- two chronic condition measures (one on diabetes, the other on asthma/ chronic obstructive pulmonary disease).
Previous: MIPS 2022—What’s New With Improvement Activities
Next: The Evolving CMS Policy on MIPS Value Pathways
DISCLAIMER AND LIMITATION OF LIABILITY: Meeting regulatory requirements is a complicated process involving continually changing rules and the application of judgment to factual situations. The Academy does not guarantee or warrant that regulators and public or private payers will agree with the Academy’s information or recommendations. The Academy shall not be liable to you or any other party to any extent whatsoever for errors in, or omissions from, any such information provided by the Academy, its employees, agents, or representatives.
COPYRIGHT© 2022, American Academy of Ophthalmology, Inc.® All rights reserved. No part of this publication may be reproduced without written permission from the publisher. American Academy of Ophthalmic Executives® and IRIS® Registry, among other marks, are trademarks of the American Academy of Ophthalmology®.